financetom
Business
financetom
/
Business
/
Microchip Technology Gears Up For Q4 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Microchip Technology Gears Up For Q4 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
May 6, 2024 5:04 AM

Microchip Technology Incorporated ( MCHP ) is expected to release earnings results for its fourth quarter, after the closing bell on May 6.

Analysts expect the Chandler, Arizona-based company to report quarterly earnings at 57 cents per share, down from $1.64 per share in the year-ago quarter. Microchip Technology ( MCHP ) is projected to report quarterly revenue of $1.33 billion, compared to $2.23 billion in the year-earlier quarter, according to data from Benzinga Pro.

On April 15, Microchip Technology ( MCHP ) said it has acquired Neuronix AI Labs. However, terms of the deal were not fisclosed.

Microchip Technology ( MCHP ) shares rose 2.1% to close at $91.36 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

Stifel analyst Tore Svanberg maintained a Buy rating and raised the price target from $98 to $102 on May 1. This analyst has an accuracy rate of 77%.

Evercore ISI Group analyst Mark Lipacis initiated coverage on the stock with an Outperform rating and a price target of $106 on April 16. This analyst has an accuracy rate of 78%.

Goldman Sachs analyst Toshiya Hari maintained a Neutral rating and cut the price target from $87 to $77 on Feb. 5. This analyst has an accuracy rate of 80%.

UBS analyst Pradeep Ramani maintained a Buy rating and cut the price target from $105 to $95 on Feb. 2. This analyst has an accuracy rate of 76%.

Needham analyst Quinn Bolton maintained a Buy rating and increased the price target from $85 to $90 on Feb. 2. This analyst has an accuracy rate of 82%.

Read This Next: Jim Cramer Says ‘You’re In Good Hands’ With This ‘Very Good’ Regional Bank, Likes General Motors

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Leading creator of child porn on 'dark web' convicted in Nevada
Leading creator of child porn on 'dark web' convicted in Nevada
Mar 7, 2024
March 7 (Reuters) - A man accused of victimizing dozens of minors as the leading purveyor of child sexual abuse material on the dark web between 2018 and 2021 was convicted on Thursday of multiple counts of child pornography and exploitation by a federal court jury in Nevada. James Patrick Burns, 55, of Sparks, Nevada, who was already a registered...
Idexx Laboratories Insider Sold Shares Worth $790,427, According to a Recent SEC Filing
Idexx Laboratories Insider Sold Shares Worth $790,427, According to a Recent SEC Filing
Mar 7, 2024
05:06 PM EST, 03/07/2024 (MT Newswires) -- Sophie V. Vandebroek, Director, on March 05, 2024, sold 1,404 shares in Idexx Laboratories ( IDXX ) for $790,427. Following the Form 4 filing with the SEC, Vandebroek has control over a total of 9,389 shares of the company, with 1,216 shares held directly and 8,173 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/874716/000087471624000064/xslF345X03/wk-form4_1709848802.xml Price: 563.25,...
BigBear.ai Q4 Misses Estimates; Issues Outlook -- Shares Fall After-Hours
BigBear.ai Q4 Misses Estimates; Issues Outlook -- Shares Fall After-Hours
Mar 7, 2024
05:07 PM EST, 03/07/2024 (MT Newswires) -- BigBear.ai ( BBAI ) reported a Q4 net loss late Thursday of $0.14 per diluted share, narrower than a loss of $0.23 a year earlier. Analysts polled by Capital IQ expected a loss of $0.05. Revenue for the quarter ended Dec. 31 was $40.6 million, up from $40.4 million a year earlier. Analysts...
Idexx Laboratories Insider Sold Shares Worth $4,525,596, According to a Recent SEC Filing
Idexx Laboratories Insider Sold Shares Worth $4,525,596, According to a Recent SEC Filing
Mar 7, 2024
05:06 PM EST, 03/07/2024 (MT Newswires) -- James F Polewaczyk, Executive Vice President, on March 06, 2024, sold 8,104 shares in Idexx Laboratories ( IDXX ) for $4,525,596. Following the Form 4 filing with the SEC, Polewaczyk has control over a total of 10,711 shares of the company, with 10,711 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/xslF345X03/wk-form4_1709848825.xml Price: 563.25, Change: +0.03,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved